Freedom of Information request on penfluridol licensing in the UK (FOI 21-539)
Published 13 August 2021
© Crown copyright 2021
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-14-june-2021/freedom-of-information-request-on-penfluridol-licensing-in-the-uk-foi-21-539
14th June 2021 FOI 21/539
Dear
Thank you for your email.
According to our records we confirm this product is not licensed in the UK and as such we do not hold this information.
Whilst penfluridol is not licensed for use in the UK, we can confirm to up to and including 6th June 2021 we have received 1 Adverse Drug Reaction (ADR) report in association with penfluridol reporting ‘Increased viscosity of upper respiratory secretion’. Reporting of a particular reaction does not necessarily mean that it has been caused by the drug, only that the reporter has a suspicion it may have. Underlying or concurrent illnesses may be responsible and such events can also be coincidental.
If you have any queries, please reply to this email.
If you are dissatisfied with the handling of your request, you have the right to ask for an internal review.
Internal review requests should be submitted within two months of the date you receive this response and addressed to: info@mhra.gov.uk
Please remember to quote the reference number above in any future communications. Please note, due to the ongoing Covid-19 situation, we are not able to accept delivery of any documents or correspondence by post or courier to any of our offices.
If you were to remain dissatisfied with the outcome of the internal review, you would have the right to apply directly to the Information Commissioner for a decision. Please bear in mind that the Information Commissioner will not normally review our handling of your request unless you have first contacted us to conduct an internal review. The Information Commissioner can be contacted at:
Information Commissioner’s Office Wycliffe House Water Lane Wilmslow Cheshire SK9 5AF
Yours sincerely,
MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency 10 South Colonnade, Canary Wharf, London E14 4PU